Total 79 cases of hospitalized patients in Surgical Department of National Sendai Hospital who received 2 to 23 units (1 unit=200m
l) of blood from healthy volunteers before and after the operation through the period from December 1970 to May 1971 were thoroughly examined for their liver functions as well as the presence of Australia (Au) antigen and antibody. Some 70% of patients studied here were more than 50 years old and under the diagnosis of intestinal cancer. For the detection of Au antigen, immunoelectrosyneresis (IEOS) and for that of Au antibody, most sensitive passive hemagglutination (PHA) test were employed.
Obtained results can be summarized as follows:
1) Eighteen cases in total received transfusion of one or two units of Au antigen positive blood. Eight out of 18 (44.4%) developed antigenemia and another 7 out of 18 revealed antibody response. Thus 15 cases out of 18 responded in some way to the transfused Au antigen.
2) When the blood judged to be Au antigen negative by means of IEOS was transfused to 61 cases, 21 out of 61 (34.4%) showed antibody response to Au antigen. Such an antibody response was more evident among patients of older age and was first noticed in this study. It might be a booster effect of transfused antigen, even undetectible in IEOS.
3) During this survey, 8 cases out of 79 (10.1%) developed hepatitis, on the basis of laboratory findings. Six such cases out of 8 received Au negative sera. Two out of 6 were hepatitis of short incubation period accompanying jaundice and their highest titer in T. T. T. was 4.9 and 8.3, respectively.
4) Among 61 patients receiving Au negative blood, hepatitis incidence was only 1 out of 21 patients who developed Au antibody after-wards (4.8%). This ratio was contrasted with the hepatitis incidence of 5 out of 40 (12.5%), who did not develope antibody. The former group was considered to be in immune state to hepatitis agent.
抄録全体を表示